You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 26, 2026

Drugs in MeSH Category Food Preservatives


✉ Email this page to a colleague

« Back to Dashboard


Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Hope Pharms SODIUM NITRITE sodium nitrite SOLUTION;INTRAVENOUS 203922-001 Feb 14, 2012 RX Yes Yes 9,687,506 ⤷  Start Trial Y ⤷  Start Trial
Hope Pharms SODIUM NITRITE sodium nitrite SOLUTION;INTRAVENOUS 203922-001 Feb 14, 2012 RX Yes Yes 8,568,793 ⤷  Start Trial Y Y ⤷  Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Market Dynamics and Patent Landscape for Drugs in NLM MeSH Class: Food Preservatives

Last updated: February 20, 2026

What is the scope of drugs classified as food preservatives in NLM MeSH?

The NLM MeSH (Medical Subject Headings) classification covers chemicals used to prevent spoilage and extend shelf life of food products. These substances include both natural extracts and synthetic compounds. The class primarily involves substances such as nitrates, nitrites, benzoates, sorbates, and certain preservatives with pharmacological applications. Despite their primary use in food, some preservatives are under investigation for medical applications, including antimicrobial therapies and drug stabilization.

How large is the current market for food preservatives, and what are its key drivers?

The global food preservatives market was valued at approximately USD 3.3 billion in 2022, with projections reaching USD 4.8 billion by 2030, at a CAGR of 4.7%.

Key drivers include:

  • The surge in processed food consumption in emerging markets.
  • Stringent food safety regulations enforcing preservative use.
  • Rising awareness of foodborne illnesses.
  • Development of natural preservative alternatives.

Market segmentation:

Segment Market Share (2022) Growth Rate (2022-2030)
Synthetic preservatives 65% CAGR 4.2%
Natural preservatives 35% CAGR 6.3%

Synthetic preservatives dominate due to cost-effectiveness and proven efficacy. However, demand for natural preservatives increases, driven by consumer preference for clean-label products.

What are the major patent trends in food preservatives with potential medical applications?

Patent filings indicate evolving innovation targeted at enhancing preservative efficacy, reducing toxicity, and expanding medical utility.

Patent activity overview (2012–2022)

  • Total patent filings: Approximately 2,500 worldwide.
  • Leading jurisdictions: United States (38%), China (22%), Europe (18%).

Key patent categories:

  1. Nanoencapsulation of preservatives: Improves stability and controlled release.
  2. Biodegradable preservatives: Focus on natural compounds with minimal environmental impact.
  3. Hybrid formulations: Combining synthetic and natural agents for broad-spectrum activity.
  4. Drug stabilization methods: Use of preservatives to stabilize pharmaceuticals, including antibody formulations and vaccines.

Notable patent assignees:

  • Cognis (former company now part of BASF): Focused on synthetic preservatives.
  • Kemin Industries: Natural preservative technology.
  • Glaxosmithkline and Pfizer: Patented drug stabilization techniques involving preservatives.

Parallel development for medical applications:

Many patents address drug stability, utilizing preservatives initially designed for food, now adapted to pharmaceutical stability and antimicrobial coatings.

How does regulatory landscape influence market and patent activity?

Regulations impact innovation by limiting certain preservatives and encouraging development of safer alternatives.

Key regulations:

  • FAO/WHO JECFA assessments: Set maximum residue limits and safety guidelines.
  • US FDA: Approves specific food preservatives; some compounds classified as inactive pharmaceutical ingredients.
  • European Food Safety Authority (EFSA): Implements strict additive approval procedures, increasing demand for novel preservatives.

Impact:

  • Regulations restrict use of certain synthetic preservatives, catalyzing research into natural alternatives.
  • Pharmaceutical patent activity often responds to these regulatory shifts, adapting formulations to meet safety standards.

What are the competitive strategies among key players?

Leading firms pursue several approaches:

  • Patent filing and portfolio expansion: Protect innovation in natural and synthetic preservatives.
  • Mergers and acquisitions: Acquire specialized biotech firms for natural preservative technologies.
  • R&D collaborations: Partner with universities and research institutes to develop new compounds.
  • Regulatory engagement: Work with authorities to expedite approval of new preservatives.

What are the future prospects for this market?

Growth is expected to continue at a steady pace, driven by consumer trends and technological advancements. Innovation focusing on natural, biodegradable, and drug-compatible preservatives will dominate.

Emerging areas include:

  • Use of marine and plant-derived compounds.
  • Nanotechnology for encapsulated preservatives.
  • Preservatives with dual functions, such as antimicrobial and drug delivery roles.

Predictive models suggest a compound annual growth rate of 4.5% to 5.0% over the next five years, with natural preservatives leading the growth trajectory.

Key Takeaways

  • The food preservatives market is growing, with synthetic agents maintaining dominance but natural alternatives gaining ground.
  • Patent activities focus on nanotechnology, natural compounds, and drug stabilization applications.
  • Regulatory environments significantly influence market dynamics and innovation strategies.
  • Major players are investing in protected portfolios, collaborations, and natural preservative research.
  • Future growth hinges on technological advances, consumer preferences, and regulatory approvals.

FAQs

  1. What are the main natural preservatives under patent review? Plant extracts such as rosemary, thyme, and essential oils like oregano are under investigation for their antimicrobial properties and patented formulations.

  2. How do patents support the transition to natural preservatives? Patents protect innovations like extraction methods, stabilizing formulations, and delivery systems, accelerating R&D and commercialization of natural preservatives.

  3. Are any food preservatives approved for medical use? Some preservatives, such as benzoates and sorbates, are approved for drug formulations, especially for topical or injectable applications requiring antimicrobial stability.

  4. What regulatory hurdles exist for food preservative patents? Innovations must demonstrate safety for both food and pharmaceutical applications, complying with agencies like FDA and EFSA, which can prolong approval timelines.

  5. Which regions lead in patent activity and innovation? The United States and China dominate patent filings due to aggressive R&D investment and large market size; Europe also contributes significantly.


References

[1] MarketsandMarkets (2023). Food preservatives market size, share, and forecast.
[2] U.S. Food and Drug Administration (2022). List of approved food additives.
[3] European Food Safety Authority (2022). Guidance on food additive safety assessments.
[4] WIPO Patent Database (2023). Patent filings in preservatives and drug stabilization.
[5] Grand View Research (2023). Natural preservatives market analysis.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.